A malaria drug President Donald Trump took to try to prevent Covid-19 proved ineffective in the first large, high-quality study to test it on people in close contact with someone with the disease.Results published Wednesday by the...
Full ArticleCovid 19 coronavirus: Malaria drug fails to prevent Covid-19 in a rigorous study
New Zealand Herald
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: OTC Markets Group, NetCents Technology, EuroLife Brands, Pacton Gold, Tectonic Metals, Group Eleven Resources UPDATE ...
Proactive Investors
OTC Markets Group (OTCQX:OTCM) will be hosting the upcoming US Western Metals and Mining Virtual Investor Conference on Tuesday..
-
NA Proactive news snapshot: NexTech AR, EnWave Corporation, GlobeX Data, Acasti Pharma UPDATE ...
Proactive Investors
-
Coronavirus: What’s happening in the labs of pharma companies worldwide
Proactive Investors
-
Hydroxychloroquine Unlikely To Benefit Covid-19 Patients: Study
RTTNews
-
The Latest: WHO official says malaria drug won't stop deaths
SeattlePI.com
Advertisement
More coverage
Malaria drug didn't help virus patients, big UK study finds
SeattlePI.com
Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines..
-
What you need to know today about the virus outbreak
SeattlePI.com
-
U of M study: Hydroxychloroquine a poor defense against Covid-19
bizjournals
-
The Latest: Pakistan, India coronavirus cases, deaths spike
SeattlePI.com
-
Malaria drug promoted by Trump did not prevent COVID-19 Infections, study finds
Seattle Times